Naratuximab (Anti-TSPAN26 / CD37)

Synonyms: Anti-TSPAN26/CD37 Reference Antibody (naratuximab)

Naratuximab (Anti-TSPAN26 / CD37) is a humanized monoclonal antibody targeting CD37 (TSPAN26). It can be used to synthesize an ADC compound, naratuximab emtansine which is used in treatment of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL). MW : 150 KD.

Naratuximab (Anti-TSPAN26 / CD37)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 6.37mg/ml Endotoxin Level: <1EU/mg
99

Biological Activity

Description Naratuximab (Anti-TSPAN26 / CD37) is a humanized monoclonal antibody targeting CD37 (TSPAN26). It can be used to synthesize an ADC compound, naratuximab emtansine which is used in treatment of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL). MW : 150 KD.

Product Details

CAS No. 1622327-39-2
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Naratuximab (Anti-TSPAN26 / CD37) | Naratuximab (Anti-TSPAN26 / CD37) supplier | purchase Naratuximab (Anti-TSPAN26 / CD37) | Naratuximab (Anti-TSPAN26 / CD37) cost | Naratuximab (Anti-TSPAN26 / CD37) manufacturer | order Naratuximab (Anti-TSPAN26 / CD37) | Naratuximab (Anti-TSPAN26 / CD37) distributor